A L Barry - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

A L Barry

Showing results (391-400 of 420) with videos related to

Pageof 42

Sort By:

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 1, 1996

Methods of measuring susceptibility of anaerobic bacteria to trovafloxacin, including quality control parametersA L Barry, P C Fuchs, C Thornsberry, et al.

Diagnostic Microbiology and Infectious Disease|March 1, 1987

CI-934, a new difluoroquinolone: in vitro antibacterial activity and proposed disk diffusion test interpretive criteriaP C Fuchs, A L Barry, R N Jones, et al.

Journal of Clinical Microbiology|April 1, 1992

Interpretive criteria and quality control limits for testing susceptibility of Neisseria gonorrhoeae to enoxacinA L Barry, M A Cohen, J C Sesnie, et al.

Diagnostic Microbiology and Infectious Disease|May 1, 1997

Reproducibility of broth microdilution and disk diffusion susceptibility tests of nine antimicrobial agents against Streptococcus pneumoniae ATCC 49619P C Fuchs, A L Barry, S D Brown, et al.

The Journal of Antibiotics|September 1, 1979

Rosamicin: in vitro activity comparison with erythromycin and other antibiotics against clinical isolates from the genito-urinary tract and Neisseria meningitidisP C Fuchs, C Thornsberry, A L Barry, et al.

Antimicrobial Agents and Chemotherapy|July 1, 1980

Cefotaxime: in vitro activity and tentative interpretive standards for disk susceptibility testingP C Fuchs, A L Barry, C Thornsberry, et al.

Journal of Clinical Microbiology|December 1, 1996

Detection of extended-spectrum-beta-lactamase-producing members of the family Enterobacteriaceae with Vitek ESBL testC C Sanders, A L Barry, J A Washington, et al.

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 1, 1988

In vitro activity of FCE 22101, imipenem, and ceftazidime against over 6,000 bacterial isolates and MIC quality control limits of FCE 22101A L Barry, K E Aldridge, S D Allen, et al.

Antimicrobial Agents and Chemotherapy|October 1, 1987

Influence of cation supplements on activity of netilmicin against Pseudomonas aeruginosa in vitro and in vivoA L Barry, G H Miller, C Thornsberry, et al.

Journal of Clinical Microbiology|November 1, 1992

Interpretive criteria and quality control parameters for testing susceptibility of Haemophilus influenzae to enoxacin, ofloxacin, and temafloxacinA L Barry, J H Jorgensen, D J Hardy, et al.

Pageof 42

Search research articles

Showing results (391-400 of 420) with videos related to

Sort By:

Pageof 42

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 1, 1996

Methods of measuring susceptibility of anaerobic bacteria to trovafloxacin, including quality control parametersA L Barry, P C Fuchs, C Thornsberry, et al.

Diagnostic Microbiology and Infectious Disease|March 1, 1987

CI-934, a new difluoroquinolone: in vitro antibacterial activity and proposed disk diffusion test interpretive criteriaP C Fuchs, A L Barry, R N Jones, et al.

Journal of Clinical Microbiology|April 1, 1992

Interpretive criteria and quality control limits for testing susceptibility of Neisseria gonorrhoeae to enoxacinA L Barry, M A Cohen, J C Sesnie, et al.

Diagnostic Microbiology and Infectious Disease|May 1, 1997

Reproducibility of broth microdilution and disk diffusion susceptibility tests of nine antimicrobial agents against Streptococcus pneumoniae ATCC 49619P C Fuchs, A L Barry, S D Brown, et al.

The Journal of Antibiotics|September 1, 1979

Antimicrobial Agents and Chemotherapy|July 1, 1980

Cefotaxime: in vitro activity and tentative interpretive standards for disk susceptibility testingP C Fuchs, A L Barry, C Thornsberry, et al.

Journal of Clinical Microbiology|December 1, 1996

Detection of extended-spectrum-beta-lactamase-producing members of the family Enterobacteriaceae with Vitek ESBL testC C Sanders, A L Barry, J A Washington, et al.

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 1, 1988

In vitro activity of FCE 22101, imipenem, and ceftazidime against over 6,000 bacterial isolates and MIC quality control limits of FCE 22101A L Barry, K E Aldridge, S D Allen, et al.

Antimicrobial Agents and Chemotherapy|October 1, 1987

Influence of cation supplements on activity of netilmicin against Pseudomonas aeruginosa in vitro and in vivoA L Barry, G H Miller, C Thornsberry, et al.

Journal of Clinical Microbiology|November 1, 1992

Interpretive criteria and quality control parameters for testing susceptibility of Haemophilus influenzae to enoxacin, ofloxacin, and temafloxacinA L Barry, J H Jorgensen, D J Hardy, et al.

Pageof 42